Article
Genomic features and its potential implication in bone oligometastatic NSCLC.
BMC pulmonary medicine - 8 Feb 2023
Liao Rongxin, Yi Guangming, Shen Lu, Zhang Xiaoyue, Xu Zaicheng, Peng Yuan, Yang Zhenzhou
Abstract excerpt
OBJECTIVES: Emerging evidence have demonstrated that oligometastatic non-small cell lung cancer (NSCLC) can achieve clinical benefit from local consolidative therapy. Bone oligometastasis is common in advanced lung cancer, but little is known about its molecular features. The purpose of our study aimed to investigate the genomic landscape bone oligometastatic NSCLC. METHODS: We collected paired blood and tissue...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
